Effect of lorcaserin in different age groups: a post hoc analysis of patients from the BLOOM, BLOSSOM and BLOOM-DM studies.
Ken FujiokaM MalhotraC PerdomoC M ApovianPublished in: Obesity science & practice (2019)
In summary, this post hoc analysis demonstrates that lorcaserin treatment in patients with and without T2D was safe and effective at reducing weight across all age groups analysed. Weight loss appeared to be greater for older patients; additional analyses are warranted to confirm these findings and to better understand the factors for improved weight loss.
Keyphrases
- weight loss
- bariatric surgery
- end stage renal disease
- roux en y gastric bypass
- gastric bypass
- ejection fraction
- chronic kidney disease
- newly diagnosed
- body mass index
- peritoneal dialysis
- prognostic factors
- physical activity
- type diabetes
- patient reported outcomes
- insulin resistance
- skeletal muscle
- obese patients
- combination therapy
- body weight
- smoking cessation